These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21034597)

  • 21. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction.
    Ishii H; Ichimiya S; Kanashiro M; Amano T; Imai K; Murohara T; Matsubara T
    Circulation; 2005 Aug; 112(9):1284-8. PubMed ID: 16116055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thorombolytic therapy with rescue percutaneous coronary intervention versus primary percutaneous coronary intervention in patients with acute myocardial infarction: a multicenter randomized clinical trial.
    Gao RL; Han YL; Yang XC; Mao JM; Fang WY; Wang L; Shen WF; Li ZQ; Jia GL; Lü SZ; Wei M; Zeng DY; Chen JL; Qin XW; Xu B; DU CH;
    Chin Med J (Engl); 2010 Jun; 123(11):1365-72. PubMed ID: 20819587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial.
    Gibson CM; Murphy SA; Montalescot G; Morrow DA; Ardissino D; Cohen M; Gulba DC; Kracoff OH; Lewis BS; Roguin N; Antman EM; Braunwald E;
    J Am Coll Cardiol; 2007 Jun; 49(23):2238-46. PubMed ID: 17560287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of tongxinluo on mini-swine vascular endothelial integrity and myocardial no-reflow in early reperfusion of acute myocardial infarction].
    Zhang HT; Yang YJ; Wu YL; Cheng YT; Kang S; Zhao JL; Meng L; Tian Y; Zhang YW; Ye J; Meng XM
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1421-5. PubMed ID: 19671339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Ndrepepa G; Tiroch K; Keta D; Fusaro M; Seyfarth M; Pache J; Mehilli J; Schömig A; Kastrati A
    Circ Cardiovasc Interv; 2010 Feb; 3(1):27-33. PubMed ID: 20118156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention.
    Uyarel H; Cam N; Okmen E; Kasikcioglu H; Tartan Z; Akgul O; Simsek D; Cetin M; Bozbeyoglu E; Buturak A; Uzunlar B
    Am Heart J; 2006 Jun; 151(6):1239.e1-7. PubMed ID: 16781226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: a benefit of postconditioning.
    Laskey WK; Yoon S; Calzada N; Ricciardi MJ
    Catheter Cardiovasc Interv; 2008 Aug; 72(2):212-20. PubMed ID: 18546233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early ST-segment recovery after primary percutaneous coronary intervention accurately predicts long-term prognosis after acute myocardial infarction.
    Verouden NJ; Haeck JD; Kuijt WJ; Koch KT; Henriques JP; Baan J; Vis MM; Piek JJ; Tijssen JG; de Winter RJ
    Am Heart J; 2010 Jun; 159(6):1005-11. PubMed ID: 20569713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sestamibi single photon emission computed tomography immediately after primary percutaneous coronary intervention identifies patients at risk for large infarcts.
    Kaltoft A; Bøttcher M; Sand NP; Rehling M; Andersen NT; Zijlstra F; Nielsen TT
    Am Heart J; 2006 May; 151(5):1108-14. PubMed ID: 16644346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
    Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
    Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular function in acute myocardial infarction treated with thrombolysis followed by early versus late invasive strategy.
    Mistry N; Bøhmer E; Hoffmann P; Müller C; Bjørnerheim R; Kjeldsen SE; Halvorsen S
    Am Heart J; 2010 Jul; 160(1):73-9. PubMed ID: 20598975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Beneficial effects of Tong-xin-luo (herb) on myocardial no-reflow after acute myocardial infarction and reperfusion: experiment of mini-swine model].
    Yang YJ; Zhao JL; Jing ZC; Wu YJ; You SJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):883-8. PubMed ID: 16029525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.
    Kaltoft A; Kelbaek H; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    J Am Coll Cardiol; 2010 Aug; 56(8):641-5. PubMed ID: 20688033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective multicenter randomized trial comparing physician versus patient transfer for primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.
    Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
    Chin Med J (Engl); 2008 Mar; 121(6):485-91. PubMed ID: 18364130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New method of intracoronary adenosine injection to prevent microvascular reperfusion injury in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Grygier M; Araszkiewicz A; Lesiak M; Janus M; Kowal J; Skorupski W; Pyda M; Mitkowski P; Grajek S
    Am J Cardiol; 2011 Apr; 107(8):1131-5. PubMed ID: 21310372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction.
    Brodie BR; Stuckey TD; Hansen C; VerSteeg DS; Muncy DB; Moore S; Gupta N; Downey WE
    Am J Cardiol; 2005 Feb; 95(3):343-8. PubMed ID: 15670542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial.
    Wang Y; Wang X; Wang J; Li B; Yu R; Hu Y; Li X; Peng G; Zhang M; Zhu M
    Trials; 2020 Mar; 21(1):287. PubMed ID: 32197640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.